Provides of wearable medical devices for individuals with chronic diseases. It offers wireless patch type insulin pump, leveraging its proprietary low power electroosmotic pump technology. It provides wearable device for insulin infusion, controls the drug infusion volume through a smartphone app. The electroosmotic pump based on original core technology, enables an accurate infusion with the infusion accuracy. Founded in 2015, headquartered in Seoul, South Korea. The company has raised $17.2M at the Series B stage backed by investors including i-SENS, Atinum Investment, Aju IB Investment, Korea Investment Holdings. Operating in High Tech > Wearable Technology, Internet of Things - Industry Applications > Wearable Technology.
← All startups
CareMedi
Series BProvides of wearable medical devices for individuals with chronic diseases. It offers wireless patch type insulin pump, leveraging its proprietary low power electroosmotic pump technology. It provides wearable device for insulin infusion, controls the drug infusion volume through a smartphone app. The electroosmotic pump based on original core technology, enables an accurate infusion with the infusion accuracy.…
About
Business model
Wearable Technology > Health and Wellness Devices > On Body Drug Delivery > Insulin,
Diabetes > Medical Devices > Therapeutic Devices > Insulin Delivery Systems > Insulin Patches,
Drug Delivery > Patches > Iontophoretic
Institutional investors
i-SENSAtinum InvestmentAju IB InvestmentKorea Investment Holdings
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Full list of active funds — filter by stage, check size, and geography.